AARD vs REGN: Which Stock is Better?
Side-by-side comparison of Aardvark Therapeutics, Inc. Common Stock and Regeneron Pharmaceuticals Inc in 2026
AARD
Aardvark Therapeutics, Inc. Common Stock
—
REGN
Regeneron Pharmaceuticals Inc
$635.45
Key Metrics Comparison
| Metric | AARD | REGN | Winner |
|---|---|---|---|
| Market Cap | $284.41M | $59.10B | REGN |
| P/E Ratio | N/A | 13.91 | REGN |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze AARD
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is AARD or REGN a better investment?
Comparing AARD and REGN: Aardvark Therapeutics, Inc. Common Stock has a market cap of $284.41M while Regeneron Pharmaceuticals Inc has $59.10B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between AARD and REGN?
AARD (Aardvark Therapeutics, Inc. Common Stock) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: AARD or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: AARD or REGN?
Both AARD and REGN show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: AARD or REGN?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: AARD or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $59.10B compared to $284.41M for AARD.
Should I buy AARD or REGN in 2026?
Both AARD and REGN have investment merit. AARD trades at $N/A while REGN trades at $635.45. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between AARD and REGN stock?
Key differences: Market Cap ($284.41M vs $59.10B), P/E Ratio (N/A vs 13.9x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy AARD or REGN in 2026?
The choice between AARD and REGN depends on your investment goals. REGN shows higher revenue growth (0.0%). REGN has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between AARD and REGN?
AARD (Aardvark Therapeutics, Inc. Common Stock) has a market cap of $284.41M, while REGN (Regeneron Pharmaceuticals Inc) has a market cap of $59.10B. REGN is the larger company by market value.